XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statements of Cash Flows - USD ($)
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,018,580) $ (6,326,866)
Adjustments to reconcile net loss to net cash used in operating activities    
Preferred shares issued as compensation 44,152 105,658
Preferred shares issued pursuant to license agreement   935,088
Common shares issued as compensation and for services 119,572 129,018
Warrants granted to Scientific Advisory Board 886 3,781
Depreciation 552,445 529,167
Amortization 6,202 6,202
Changes in operating assets and liabilities:    
Prepaid expenses 69,904 204,118
Other assets 23,257 (45,702)
Accounts payable 4,735 (77,029)
Accounts payable - related party 29,484 42,048
Accrued expenses (3,524) 967
NET CASH USED IN OPERATING ACTIVITIES (4,171,467) (4,493,550)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (149,146) (248,986)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payment of loan payable (94,788) (164,599)
Deferred financing costs   (37,408)
NET CASH (USED IN) FINANCING ACTIVITIES (94,788) (202,007)
NET CHANGE IN CASH AND CASH EQUIVALENTS (4,415,401) (4,944,543)
Cash and cash equivalents at beginning of period 14,066,359 20,516,677
Cash and cash equivalents at end of period 9,650,958 15,572,134
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Interest paid $ 938 3,488
Non-Cash Financing and Investing Activities:    
Directors and Officers Insurance financed through loan   $ 234,198